EducationPhD University of Oslo (Norway), 1996 (Epidemiology)
MS University of Zagreb (Yugoslavia), 1991 (Biostatistics)
MD University of Zagreb (Yugoslavia), 1987 (Internal Medicine)
Contact Infoemail: firstname.lastname@example.org
4333 Brooklyn Ave NE, Rm 14-315
Seattle, WA 98195-9455
campus box: 359455
Dr. Kopjar is an internationally recognized scholar and expert in biostatistics and clinical epidemiology. He serves as an author/co-author on over 500 published original articles, reviews, technical reports and abstracts. His research interests include: spinal cord injury and diseases, neurosurgery, orthopaedics, preventive medicine and healthcare reform. Dr. Kopjar has been actively participating in the design, management and analysis of clinical trials and medical research for more than 30 years. He is a frequent contributor to such peer-reviewed publications as the Journal of Neurosurgery, the American Journal of Public Health, Spine and the Journal of Bone and Joint Surgery. In the 1990’s he served as the research director for the Norwegian Foundation for Health Services Research and department head of the Section for Preventive Medicine at the Norwegian National Institute of Public Health. As a consultant, he works closely with the leading global pharmaceutical, medical device and venture capital firms in regards to determining the efficacy, safety and investment value of medical technologies. Dr. Kopjar is active in a variety of research organizations including: AOSpine North America, The North American Spine Society (NASS), Cervical Spine Research Society (CSRS) and the International Scholarly Research Network (ISRN). He serves on the editorial board and as a reviewer for a number of academic journals and he is the current director of the Executive Master of Public Health program at the University of Washington. Dr. Kopjar holds the title of Distinguished Professor at Chongqing University in China. In the 2000's he held the title of Adviser to the Minister of Health for two European governments. He is a past recipient of the prestigious John M. Eisenberg Article-of-the-Year award.
Witiw CD, Tetreault LA, Smieliauskas F, Kopjar B, Massicotte EM, Fehlings MG. Surgery for degenerative cervical myelopathy: a patient-centered quality of life and health economic evaluation. Spine J. 2017 Jan;17(1):15-25. doi: 10.1016/j.spinee.2016.10.015. PMID: 27793760
Nagoshi N, Tetreault LA, Nakashima H, Nouri A, Arnold P, Zileli M, Tan G, Kopjar B, Fehlings MG. Do Caucasians and East Asians have Different Outcomes Following Surgery for the Treatment of Degenerative Cervical Myelopathy?: Results From the Prospective Multicenter AOSpine International Study. Spine (Phila Pa 1976). 2016 Sep 15;41(18):1428-35. doi: 10.1097/BRS.0000000000001555. PMID: 26974832
Bohm PE, Fehlings MG, Kopjar B, Tetreault LA, Vaccaro AR, Anderson KK, Arnold PM. Psychometric properties of the 30-m walking test in patients with degenerative cervical myelopathy: results from two prospective multicenter cohort studies. Spine J. 2016 Aug 31. pii: S1529-9430(16)30923-8. doi: 10.1016/j.spinee.2016.08.033. [Epub ahead of print] PMID: 27592193
Fehlings MG, Kopjar B, Grossman RG. 329?Efficacy and Safety of Riluzole in Acute Spinal Cord Injury: Rationale and Design of AOSpine Phase III Multicenter Double-Blinded Randomized Controlled Trial (RISCIS). Neurosurgery. 2016 Aug;63 Suppl 1:196. doi: 10.1227/01.neu.0000489818.21218.72. PMID: 27399527
PI: Kopjar Dates: 4/1/2011 - 12/31/2016
The aim of this study is to evaluate efficacy and safety of riluzole in the treatment of patients with acute spinal cord injury (SCI).
Efficacy of Riluzole in Surgical Treatment for Cervical Spondylotic Myelopathy (CSM-Protect)
Study of the efficacy of Riluzole in patients with cervical spondylotic myelopathy undergoing surgical treatment. A randomized, double-blind, placebo-controlled multi-center study